Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Fondaparinux (trade name Arixtra) is an anticoagulant medication chemically related to low molecular weight heparins. It is marketed by Viatris. A generic version developed by Alchemia is marketed within the US by Dr. Reddy's Laboratories.
Applications, Medical uses & Pharmacology
Explore the main themes, entities and connections around Fondaparinux. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
heparin antithrombin factor marketed binding trade arixtra us patients xa sequence within 23 anticoagulant viatris used reducing risk substantially use
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Fondaparinux | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Fondaparinux | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Fondaparinux | ATC code | B01AX05 (WHO) | 1.00 | infobox |
| Fondaparinux | Bioavailability | N/A | 1.00 | infobox |
| Fondaparinux | CAS Number | 104993-28-4 Y | 1.00 | infobox |
| Fondaparinux | CAS Number | decasodium salt: 114870-03-0 Y | 1.00 | infobox |
| Fondaparinux | ChEMBL | ChEMBL1201202 N | 1.00 | infobox |
| Fondaparinux | ChemSpider | 552174 Y | 1.00 | infobox |
| Fondaparinux | CompTox Dashboard (EPA) | DTXSID10146903 | 1.00 | infobox |
| Fondaparinux | DrugBank | DB00569 Y | 1.00 | infobox |
| Fondaparinux | Elimination half-life | 17-21 hours | 1.00 | infobox |
| Fondaparinux | Formula | C31H43N3Na10O49S8 | 1.00 | infobox |
| Fondaparinux | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Fondaparinux | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Fondaparinux | Legal status | US: ℞-only | 1.00 | infobox |
| Fondaparinux | Legal status | EU: Rx-only | 1.00 | infobox |
| Fondaparinux | License data | EU EMA: by INN | 1.00 | infobox |
| Fondaparinux | License data | US DailyMed: Fondaparinux | 1.00 | infobox |
| Fondaparinux | Metabolism | renally excreted unchanged | 1.00 | infobox |
| Fondaparinux | Molar mass | 1728.03 g·mol−1 | 1.00 | infobox |
| Fondaparinux | Protein binding | 94% | 1.00 | infobox |
| Fondaparinux | PubChem CID | 636380 | 1.00 | infobox |
| Fondaparinux | Routes of administration | Subcutaneous | 1.00 | infobox |
| Fondaparinux | Trade names | Arixtra | 1.00 | infobox |
| Fondaparinux | UNII | J177FOW5JL | 1.00 | infobox |
| Fondaparinux | UNII | decasodium salt: X0Q6N9USOZ Y | 1.00 | infobox |
| Fondaparinux | is a | synthetic pentasaccharide factor Xa inhibitor | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.